FDA Authorizes Marketing of EndoRotor System

TUESDAY, Dec. 29, 2020 -- The U.S. Food and Drug Administration granted marketing authorization to the EndoRotor System, which provides a minimally invasive way to resect and remove necrotic tissue for patients with walled-off pancreatic necrosis...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news